Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
Director departure
|
|
CONSTELLATION PHARMACEUTICALS INC (CNST)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/04/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/02/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/01/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 06/05/2020 |
SC 13G
| GREAT POINT PARTNERS LLC reports a 5.5% stake in Constellation Pharmaceuticals, Inc. |
| 02/14/2020 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/14/2020 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 11/18/2019 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 10/11/2019 |
SC 13G
| Bain Capital Life Sciences Fund, L.P. reports a 7.7% stake in Constellation Pharmaceuticals, Inc. |
| 02/13/2019 |
SC 13G
| COLUMN GROUP L P reports a 18.3% stake in Constellation Pharmaceuticals, Inc. |
| 02/13/2019 |
SC 13G
| THIRD ROCK VENTURES LP reports a 11.8% stake in Constellation Pharmaceuticals, Inc. |
| 02/13/2019 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 10/31/2018 |
SC 13G
| Casdin Capital, LLC reports a 5.9% stake in Constellation Pharmaceuticals, Inc. |
| 08/02/2018 |
SC 13G
| VENROCK ASSOCIATES V LP reports a 6.8% stake in Constellation Pharmaceuticals, Inc. |
| 07/30/2018 |
SC 13G
| Cormorant Asset Management, LLC reports a 5.7% stake in Constellation Pharmaceuticals, Inc. |
| 07/30/2018 |
SC 13G
| Topspin Fund L.P. reports a 6.9% stake in Constellation Pharmaceuticals Inc. |
| 07/25/2018 |
SC 13G
| REGENTS OF THE UNIVERSITY OF CALIFORNIA reports a 8.9% stake in Constellation Pharmaceuticals, Inc. |
| 07/23/2018 |
SC 13G
| Flynn James E reports a 3.2% stake in Constellation Pharmaceuticals, Inc. |
|
|